The global Healthcare Laboratory Information market accounted for US$ 1.98 Bn in 2020 with a considerable CAGR of 8.7% during the forecast period of 2021 to 2028.
Healthcare laboratory information is used to effectively manage associated data and samples to increase efficiency and productivity. The unprecedented rise of a covid-19 pandemic has involved enormous amounts of lab testing that has eventually increased the workload on lab personnel to maintain a massive amount of data. Healthcare laboratory information has made it easy for healthcare professionals to automate workflows, integrate instruments, manage samples, and associate information of patient’s tests. From record books to spreadsheets, conventional methods of data recording are lacking to maintain the requirements of a modern laboratory. Healthcare lab information can make the process of storing and analyzing complex data samples simple and easy.
Report coverage
| Market |
Healthcare Laboratory Information Market |
| Analysis Period |
2017 - 2028 |
| Base Year |
2020 |
| Forecast Data |
2021 - 2028 |
| Segments Covered |
By Product Type, By End-Use, By Component, By Deployment Model, and By Geography |
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
Abbott, Agaram Technologies Pvt Ltd, AgileBio LLC, Agilent Technologies, Benchling, Inc., CSols Inc., Genologics, LabLynx, Inc., ID Business Solutions Ltd., Infosys, LabVantage Solutions, Inc., LabWare, PerkinElmer, Inc., Starlims, Tech Mahindra, Thermo Fisher Scientific, and Waters Corporation, and among others
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
| Customization Scope |
10 hrs of free customization and expert consultation
|
Market Dynamics
Growing adoption of automation in laboratories, strict regulatory requirements, and rising R&D expenditure in healthcare settings are the primary factors driving the global healthcare laboratory information market growth. In addition, the growing demand for clinical workflow management and the increasing need for scientific data integration solutions are key healthcare laboratory information market trends. However, complex integration standards and lack of skilled personnel are the factors that might restraint the market from growing. Moreover, surging demand from emerging economies and the rising trend of cloud-based laboratory information management systems will contribute to profitable opportunities for the market in the coming years.
Growing adoption of automation in laboratories
Laboratory automation is considered one of the most notable discoveries in the recent past of laboratory diagnostics. The application of automation in the laboratory enables to perform numerous tests by analytical instruments with little interference from a professional. Another advantage of laboratory automation is that laboratories can process more workload with minimum involvement of manpower. In addition, automation minimizes the chances of errors in test results that generally occur during manual analysis. Furthermore, automation in healthcare labs improves safety by using automated systems to store and handle harmful test samples. Thus, the growing adoption of automation in labs is witnessed due to its lower costs, high throughput, improved accuracy, reduced experimental errors, and a safer environment.
Every minute, an exponential volume of healthcare data is generated and extracted for valuable insights. Currently, about 30% of the world’s data volume is being generated by the healthcare industry. It is projected that the CAGR of healthcare data will achieve more than 30% till 2025.
Market Segmentation
The global healthcare laboratory information market is segmented based on product type, deployment model, component, end-user, and region. Based on the product types segment, the market classifies as laboratory information management system (LIMS), electronic lab notebook (ELN), scientific data management system (SDMS), electronic data capture (EDC) & clinical data management systems (CDMS), chromatography data system (CDS) and enterprise content management (ECM). Among product types, the laboratory information management system (LIMS) sub-segment dominated the market with more than half of the global share in 2020. The high growth in the segment is credited to its demand in pharmaceutical companies, R&D activities, food & beverages, etc. Also, LIMS manages the workflow and information through a laboratory.
By deployment model, the segmentation bifurcates into on-premise and cloud-based. The cloud-based deployment model is in demand as they save infrastructure cost, deployment time, and other significant resources during the implementation of healthcare laboratory information solutions. Component segment is further categorized into software and services. Moreover, the end-use segment is further sub-segmented into pharmaceutical and biotechnology labs, CROs, biobanks/biorepositories, molecular diagnostics & clinical research laboratories, academic research institutes, and other end-users. Among them, the pharmaceutical and biotechnology labs segment generated the highest revenue in the year 2020 owing to the surging amount of healthcare data, higher productivity, and growing demand for research & development activities in pharmaceutical and biotechnology laboratories.
Regional Overview
North America region is expected to lead global healthcare laboratory information market during the projected period of 2021 to 2028
Among all the regions, North America generated the highest revenues in 2020, accounting for around half of the total market share. This is attributed to the growing support from government organizations, presence of advanced healthcare facilities, and rising investments in LIMS technology. Besides, growing R&D spending and easy availability of LIMS products & services are also likely to boost the North American market growth. Europe stood for the second position in the regional market, owing to the growing focus on innovations through R&D. However, the Asia-Pacific region is likely to register the fastest CAGR throughout the forecast period on account of the increasing prevalence of various diseases leading to growing need for laboratory tests. Moreover, the rising population in the region and growing emphasis on improving the efficiency of laboratories propel the APAC healthcare laboratory information market.
Competitive Landscape
This section of the report pinpoints various key vendors of the market. Some of the key players offered in the report include Abbott, Agaram Technologies Pvt Ltd, AgileBio LLC, Agilent Technologies, Benchling, Inc., CSols Inc., Genologics, LabLynx, Inc., ID Business Solutions Ltd., Infosys, LabVantage Solutions, Inc., LabWare, PerkinElmer, Inc., Starlims, Tech Mahindra, Thermo Fisher Scientific, and Waters Corporation.
Market Segmentation
Market By Product Type
- Laboratory Information Management System (LIMS)
- Electronic Lab Notebook (ELN)
- Scientific Data Management System (SDMS)
- Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
- Chromatography Data System (CDS)
- Enterprise Content Management (ECM)
Market By End-Use
- Pharmaceutical and Biotechnology Labs
- CROs
- Biobanks/Biorepositories
- Molecular Diagnostics & Clinical Research Laboratories
- Academic Research Institutes
- Others
Market By Component
Market By Deployment Model
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Healthcare Laboratory Information
1.1. Definition and Scope
1.1.1. Definition of Healthcare Laboratory Information
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Healthcare Laboratory Information market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Healthcare Laboratory Information By Product Type
1.2.3. Healthcare Laboratory Information By End-Use
1.2.4. Healthcare Laboratory Information By Deployment Model
1.2.5. Healthcare Laboratory Information by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Healthcare Laboratory Information Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Healthcare Laboratory Information Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Healthcare Laboratory Information By Product Type
4.1. Introduction
4.2. Healthcare Laboratory Information Revenue By Product Type
4.2.1. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast, By Product Type, 2017-2028
4.2.2. Laboratory Information Management System (LIMS)
4.2.2.1. Laboratory Information Management System (LIMS) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
4.2.3. Scientific Data Management System (SDMS)
4.2.3.1. Scientific Data Management System (SDMS) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
4.2.4. Electronic Lab Notebook (ELN)
4.2.4.1. Electronic Lab Notebook (ELN) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
4.2.5. Laboratory Execution Systems (LES)
4.2.5.1. Laboratory Execution Systems (LES) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
4.2.6. Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS)
4.2.6.1. Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
4.2.7. Chromatography Data System (CDS)
4.2.7.1. Chromatography Data System (CDS) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
4.2.9. Enterprise Content Management (ECM)
4.2.9.1. Enterprise Content Management (ECM) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 5. Healthcare Laboratory Information Market Revenue By End-Use
5.1. Introduction
5.2. Healthcare Laboratory Information Revenue (US$ Bn) By End-Use
5.2.1. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
5.2.2. Pharmaceutical and Biotechnology Labs
5.2.2.1. Pharmaceutical and Biotechnology Labs Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.3. CROs
5.2.3.1. CROs Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.4. Biobanks/Biorepositories
5.2.4.1. Biobanks/Biorepositories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.5. Molecular Diagnostics & Clinical Research Laboratories
5.2.5.1. Molecular Diagnostics & Clinical Research Laboratories Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.6. Academic Research Institutes
5.2.6.1. Academic Research Institutes Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.7. Others
5.2.7.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 6. Healthcare Laboratory Information Market By Component
6.1. Introduction
6.2. Healthcare Laboratory Information Revenue (US$ Bn) By Deployment Model
6.2.1. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
6.2.2. Software
6.2.2.1. Software Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3. Services
6.2.3.1. Servics Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 7. Healthcare Laboratory Information Market By Deployment Model
7.1. Introduction
7.2. Healthcare Laboratory Information Revenue (US$ Bn) By Deployment Model
7.2.1. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
7.2.2. Cloud-Based
7.2.2.1. Cloud-Based Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.3. On-Premise
7.2.3.1. On-Premise Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 8. North America Healthcare Laboratory Information Market By Country
8.1. North America Healthcare Laboratory Information Overview
8.2. U.S.
8.2.1. U.S. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
8.2.2. U.S. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
8.2.3. U.S. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
8.2.4. U.S. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
8.3. Canada
8.3.1. Canada Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
8.3.2. Canada Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
8.3.3. Canada Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
8.4. North America PEST Analysis
CHAPTER 9. Europe Healthcare Laboratory Information Market By Country
9.1. Europe Healthcare Laboratory Information Overview
9.2. U.K.
9.2.1. U.K. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
9.2.2. U.K. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
9.2.3. U.K. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
9.2.4. U.K. Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
9.3. Germany
9.3.1. Germany Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
9.3.2. Germany Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
9.3.3. Germany Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
9.3.4. Germany Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
9.4. France
9.4.1. France Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
9.4.2. France Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
9.4.3. France Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
9.5. Spain
9.5.1. Spain Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
9.5.2. Spain Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
9.5.3. Spain Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
9.5.4. Spain Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
9.6. Rest of Europe
9.6.1. Rest of Europe Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
9.6.2. Rest of Europe Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
9.6.3. Rest of Europe Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
9.6.4. Rest of Europe Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Healthcare Laboratory Information Market By Country
10.1. Asia Pacific Healthcare Laboratory Information Overview
10.2. China
10.2.1. China Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.2.2. China Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
10.2.3. China Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
10.2.4. China Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
10.3. Japan
10.3.1. Japan Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.3.2. Japan Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
10.3.3. Japan Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
10.3.4. Japan Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
10.4. India
10.4.1. India Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.4.2. India Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
10.4.3. India Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
10.4.4. India Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
10.5. Australia
10.5.1. Australia Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.5.2. Australia Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
10.5.3. Australia Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
10.5.4. Australia Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
10.6. South Korea
10.6.1. South Korea Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.6.2. South Korea Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
10.6.3. South Korea Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
10.6.4. South Korea Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
10.7.2. Rest of Asia-Pacific Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
10.7.3. Rest of Asia-Pacific Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
10.7.4. Rest of Asia-Pacific Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Healthcare Laboratory Information Market By Country
11.1. Latin America Healthcare Laboratory Information Overview
11.2. Brazil
11.2.1. Brazil Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.2.2. Brazil Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
11.2.3. Brazil Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
11.2.4. Brazil Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
11.3. Mexico
11.3.1. Mexico Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.3.2. Mexico Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
11.3.3. Mexico Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
11.3.4. Mexico Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
11.4. Rest of Latin America
11.4.1. Rest of Latin America Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
11.4.2. Rest of Latin America Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
11.4.3. Rest of Latin America Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
11.4.4. Rest of Latin America Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Healthcare Laboratory Information Market By Country
12.1. Middle East & Africa Healthcare Laboratory Information Overview
12.2. GCC
12.2.1. GCC Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
12.2.2. GCC Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
12.2.3. GCC Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
12.2.4. GCC Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
12.3. South Africa
12.3.1. South Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
12.3.2. South Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
12.3.3. South Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
12.3.4. South Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Product Type, 2017-2028
12.4.2. Rest of Middle East & Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By End-Use, 2017-2028
12.4.3. Rest of Middle East & Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Component, 2017-2028
12.4.4. Rest of Middle East & Africa Healthcare Laboratory Information Revenue (US$ Bn) and Forecast By Deployment Model, 2017-2028
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Healthcare Laboratory Information
13.1. Healthcare Laboratory Information Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Healthcare Laboratory Information market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Abbott
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Bn), 2019
14.1.3.2. Abbott 2019 Healthcare Laboratory Information Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Agaram Technologies Pvt Ltd
14.3. AgileBio LLC
14.4. Agilent Technologies
14.5. Benchling, Inc.
14.6. CSols Inc.
14.7. Genologics
14.8. LabLynx, Inc.
14.9. ID Business Solutions Ltd.
14.10. Infosys
14.11. LabVantage Solutions, Inc.
14.12. LabWare
14.13. PerkinElmer, Inc.
14.14. Starlims
14.15. Tech Mahindra
14.16. Thermo Fisher Scientific
14.17. Waters Corporation
